These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16758241)

  • 1. Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.
    Coccurello R; Caprioli A; Ghirardi O; Conti R; Ciani B; Daniele S; Bartolomucci A; Moles A
    Psychopharmacology (Berl); 2006 Jul; 186(4):561-71. PubMed ID: 16758241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 30 days of continuous olanzapine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice.
    Coccurello R; Brina D; Caprioli A; Conti R; Ghirardi O; Schepis F; Moles A
    J Clin Psychopharmacol; 2009 Dec; 29(6):576-83. PubMed ID: 19910724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of the adverse effects of olanzapine on lipid metabolism with the antiepileptic zonisamide.
    Stefanidis A; Watt MJ; Cowley MA; Oldfield BJ
    Neuropharmacology; 2017 Sep; 123():55-66. PubMed ID: 28400260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis.
    Graham KA; Perkins DO; Edwards LJ; Barrier RC; Lieberman JA; Harp JB
    Am J Psychiatry; 2005 Jan; 162(1):118-23. PubMed ID: 15625209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic administration of olanzapine affects Behavioral Satiety Sequence and feeding behavior in female mice.
    Coccurello R; D'Amato FR; Moles A
    Eat Weight Disord; 2008 Sep; 13(3):e55-60. PubMed ID: 19011365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance.
    Lykkegaard K; Larsen PJ; Vrang N; Bock C; Bock T; Knudsen LB
    Schizophr Res; 2008 Aug; 103(1-3):94-103. PubMed ID: 18579346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model for antipsychotic-induced obesity in the male rat.
    Minet-Ringuet J; Even PC; Lacroix M; Tomé D; de Beaurepaire R
    Psychopharmacology (Berl); 2006 Sep; 187(4):447-54. PubMed ID: 16783538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.
    Fell MJ; Anjum N; Dickinson K; Marshall KM; Peltola LM; Vickers S; Cheetham S; Neill JC
    Psychopharmacology (Berl); 2007 Oct; 194(2):221-31. PubMed ID: 17581744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine (LY170053, 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine), but not the novel atypical antipsychotic ST2472 (9-piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), chronic administration induces weight gain, hyperphagia, and metabolic dysregulation in mice.
    Coccurello R; Caprioli A; Conti R; Ghirardi O; Borsini F; Carminati P; Moles A
    J Pharmacol Exp Ther; 2008 Sep; 326(3):905-11. PubMed ID: 18567835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of drug induced weight and metabolic effects: findings from an RCT in healthy volunteers treated with olanzapine, iloperidone, or placebo.
    Ballon JS; Pajvani UB; Mayer LE; Freyberg Z; Freyberg R; Contreras I; Rosenbaum M; Leibel RL; Lieberman JA
    J Psychopharmacol; 2018 May; 32(5):533-540. PubMed ID: 29444618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.
    Albaugh VL; Henry CR; Bello NT; Hajnal A; Lynch SL; Halle B; Lynch CJ
    Obesity (Silver Spring); 2006 Jan; 14(1):36-51. PubMed ID: 16493121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine affects locomotor activity and meal size in male rats.
    van der Zwaal EM; Luijendijk MC; Evers SS; la Fleur SE; Adan RA
    Pharmacol Biochem Behav; 2010 Nov; 97(1):130-7. PubMed ID: 20478328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Olanzapine Treatment Induces Disorders of Plasma Fatty Acid Profile in Balb/c Mice: A Potential Mechanism for Olanzapine-Induced Insulin Resistance.
    Li H; Fang M; Xu M; Li S; Du J; Li W; Chen H
    PLoS One; 2016; 11(12):e0167930. PubMed ID: 27973621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic central infusion of cocaine- and amphetamine-regulated transcript (CART 55-102): effects on body weight homeostasis in lean and high-fat-fed obese rats.
    Rohner-Jeanrenaud F; Craft LS; Bridwell J; Suter TM; Tinsley FC; Smiley DL; Burkhart DR; Statnick MA; Heiman ML; Ravussin E; Caro JF
    Int J Obes Relat Metab Disord; 2002 Feb; 26(2):143-9. PubMed ID: 11850744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of atypical antipsychotic drugs on body weight and food intake in dopamine D2 receptor knockout mice.
    Yoon S; Noh JS; Choi SY; Baik JH
    Biochem Biophys Res Commun; 2010 Mar; 393(2):235-41. PubMed ID: 20117094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic olanzapine administration in rats: effect of route of administration on weight, food intake and body composition.
    Mann S; Chintoh A; Giacca A; Fletcher P; Nobrega J; Hahn M; Remington G
    Pharmacol Biochem Behav; 2013 Feb; 103(4):717-22. PubMed ID: 23234835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine activates hepatic mammalian target of rapamycin: new mechanistic insight into metabolic dysregulation with atypical antipsychotic drugs.
    Schmidt RH; Jokinen JD; Massey VL; Falkner KC; Shi X; Yin X; Zhang X; Beier JI; Arteel GE
    J Pharmacol Exp Ther; 2013 Oct; 347(1):126-35. PubMed ID: 23926289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis.
    Albaugh VL; Judson JG; She P; Lang CH; Maresca KP; Joyal JL; Lynch CJ
    Mol Psychiatry; 2011 May; 16(5):569-81. PubMed ID: 20308992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.
    Minet-Ringuet J; Even PC; Goubern M; Tomé D; de Beaurepaire R
    Appetite; 2006 May; 46(3):254-62. PubMed ID: 16551485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and behavioral effects of chronic olanzapine treatment and cafeteria diet in rats.
    Muller AP; Tort AH; Gnoatto J; Moreira JD; Vinadé ER; Perry ML; Souza DO; Lara DR; Portela LV
    Behav Pharmacol; 2010 Oct; 21(7):668-75. PubMed ID: 20729714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.